This Article Abstract Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Sica, D. A Search for Related Content PubMed PubMed Citation Articles by Sica, D. A Social Bookmarking                         What's this?

Review: Rationale for combination therapy in the treatment of hypertension

Clinical Pharmacology and Hypertension, Division of Nephrology, Medical College of Virginia of Virginia Commonwealth University, Richmond, Virginia, USA, dsica@mail2. vcu.edu

The effective treatment of hypertension still poses many problems. In the last decade it has become apparent that in many patients multi-drug regimens are needed to effect blood pressure control. How best to combine medications and what might be a preferred order of initiating drugs is still open to debate and has proven the substance of many of the published guidelines on this theme. Like most matters in the clinical sector the approach to a disease — in this case hypertension — should remain highly individualised and cognisant of what can be significant cost considerations.

Key Words: fixed-dose combination therapy • hypertension • counter-regulatory mechanisms

References

• Joint National Committee, The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. Arch Intern Med 1997;157: 2413-46.[Abstract/Free Full Text]
• Guidelines Subcommittee. 1999 World Health Organization-International Society of Hypertension guidelines for the management of hypertension. J Hypertens 1999;17:151-83.[Web of Science][Medline] [Order article via Infotrieve]
• Treatment of Hypertension in Adults With Diabetes. Diabetes Care 2002;25:S71-S73.[CrossRef]
• Sica DA Rationale for fixed-dose combinations in the treatment of hypertension: the cycle repeats. Drugs 2002;62: 443-62.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Dahlof B., Devereux RB, Kjeldsen SE et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 2002;359:995-1003.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Thakkar RB, Oparil S. What do international guidelines say about therapy? J Hypertens 2001;19(suppl 3):S23-S31.[Web of Science]
• UK Prospective Diabetes Study Group, Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998;317: 703-13.[Abstract/Free Full Text]
• Hansson L., Zanchetti A., Carruthers SG et al. Effects of intensive blood pressure lowering and low dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomized trial. HOT Study Group. Lancet 1998;351:1755-62.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Ruilope LM, Campo C., Segura J., Rodicio JL What is the optimal blood pressure target in renal patients? Adv Nephrol Necker Hosp 2001;31:43-53.[Medline] [Order article via Infotrieve]
• Bakris GL, Williams M., Dworkin L. et al. Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group. Am J Kidney Dis 2000;36:646-61.[Web of Science][Medline] [Order article via Infotrieve]
• Materson BJ, Reda DJ, Cushman WC et al. Single drug therapy for hypertension in men: a comparison of six antihypertensive agents with placebo. N Engl J Med 1993;328:914-21.[Abstract/Free Full Text]
• Materson BJ, Reda DJ, Preston RA et al. for the Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents: Response to a second single antihypertensive agent used as monotherapy for hypertension after failure of the initial drug.Arch Intern Med 1995;155:1757-62.[Abstract/Free Full Text]
• Sica DA, Frishman W. Hypertension Optimal Treatment (HOT) study: successes and failures. Cardiovasc Rev Rep 1999;20:232-6.
• Haria M., Plosker GL, Markham A. Felodipine/metoprolol: a review of the fixed dose controlled release formulation in the management of essential hypertension. Drugs 2000;59:141-57.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Hilleman DE, Ryschon KL, Mohiuddin SM, Wurdeman RL Fixed-dose combination vs monotherapy in hypertension: a meta-analysis evaluation. J Hum Hypertens 1999;13: 477-83.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• de Leeuw PW, Notter T., Zilles P. Comparison of different fixed antihypertensive combination drugs: a double-blind, placebo-controlled parallel group study. J Hypertens 1997;15: 87-91.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: Final Results of the Systolic Hypertension in the Elderly Program (SHEP).JAmerMedAssoc 1991;265:3255-64.
• Bakris GL Maximizing cardiorenal benefit in the management of hypertension: achieving blood pressure goals. J Clin Hypertens 1999;1:141-7.
• Hebert LA, Kusek JW, Greene T. et al. Effects of blood pressure control on progressive renal disease in blacks and whites. Hypertension 1997;30:428-35.[Abstract/Free Full Text]
• Estacio RO, Jeffers BW, Hiatt WR et al. The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension.NEnglJMed 1998;338:645-52.[Abstract/Free Full Text]
• Sica DA, Bakris GL Type 2 diabetes: RENAAL and IDNT - the emergence of new treatment options. J Clin Hypertens 2002; 4:52-7.[CrossRef]
• Burt V., Whelton PK, Rocella EJ et al. Prevalence of hypertension in the US adult population: results from the Third National Health and Nutrition Examination Survey 1988-1991. Hypertension 1995;25:305-13.[Abstract/Free Full Text]
• Berlowitz DR, Ash AS, Hickey EC et al. Inadequate management of blood pressure in a hypertensive population. N Engl J Med 1998;339:1957-63.[Abstract/Free Full Text]
• Black HR, Elliott WJ, Neaton JD et al. Baseline Characteristics and Early Blood Pressure Control in the CONVINCE Trial. Hypertension 2001;37:12-18.[Abstract/Free Full Text]

Journal of Renin-Angiotensin-Aldosterone System, Vol. 3, No. 2, 63-65 (2002)
DOI: 10.3317/jraas.2002.019


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This Article Abstract Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Sica, D. A Search for Related Content PubMed PubMed Citation Articles by Sica, D. A Social Bookmarking                         What's this?